Patents by Inventor Chen Hermesh

Chen Hermesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150307572
    Abstract: Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
    Type: Application
    Filed: February 23, 2015
    Publication date: October 29, 2015
    Inventors: Ronen Shemesh, Zurit Levine, Amir Toporik, Chen Hermesh, Yossef Kliger, Eyal Gofer, Assaf Wool, Dvir Dahary, Yossi Cohen
  • Patent number: 8987191
    Abstract: Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: March 24, 2015
    Assignee: Compugen Ltd.
    Inventors: Ronen Shemesh, Zurit Levine, Amir Toporik, Chen Hermesh, Yossef Kliger, Eyal Gofer, Assaf Wool, Dvir Dahary, Yossi Cohen
  • Publication number: 20140005097
    Abstract: Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 2, 2014
    Applicant: Compugen Ltd.
    Inventors: Ronen Shemesh, Zurit Levine, Amir Toporik, Chen Hermesh, Yossef Kliger, Eyal Gofer, Assaf Wool, Dvir Dahary, Yossi Cohen
  • Patent number: 8492329
    Abstract: Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: July 23, 2013
    Assignee: Compugen Ltd.
    Inventors: Ronen Shemesh, Zurit Levine, Amir Toporik, Chen Hermesh, Yossef Klinger, Eyal Gofer, Assaf Wool, Dvir Dahary, Yossi Cohen
  • Publication number: 20110177998
    Abstract: Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
    Type: Application
    Filed: July 11, 2008
    Publication date: July 21, 2011
    Inventors: Ronen Shemesh, Zurit Levine, Amir Toporik, Chen Hermesh, Yossef Kliger, Eyal Gofer, Assaf Wool, Dvir Dahary, Yossi Cohen
  • Publication number: 20100183573
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Application
    Filed: February 19, 2010
    Publication date: July 22, 2010
    Applicant: COMPUGEN LTD.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran, Dvir Dahary, Liat Mintz, Hanqing Xie
  • Patent number: 7758862
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: July 20, 2010
    Assignee: Compugen Ltd.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran
  • Patent number: 7678769
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Grant
    Filed: July 23, 2007
    Date of Patent: March 16, 2010
    Assignee: Compugen, Ltd.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran, Dvir Dahary, Liat Mintz, Hanqing Xie
  • Publication number: 20090036374
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Application
    Filed: October 3, 2006
    Publication date: February 5, 2009
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran
  • Publication number: 20080159992
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Application
    Filed: July 23, 2007
    Publication date: July 3, 2008
    Applicant: COMPUGEN LTD.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran, Dvir Dahary, Liat Mintz, Hanqing Xie
  • Publication number: 20070083334
    Abstract: A method of annotating biomolecular sequences. The method comprises (a) computationally clustering the biomolecular sequences according to a progressive homology range, to thereby generate a plurality of clusters each being of a predetermined homology of the homology range; and (b) assigning at least one ontology to each cluster of the plurality of clusters, the at least one ontology being: (i) derived from an annotation preassociated with at least one biomolecular sequence of each cluster; and/or (ii) generated from analysis of the at least one biomolecular sequence of each cluster thereby annotating biomolecular sequences.
    Type: Application
    Filed: May 31, 2006
    Publication date: April 12, 2007
    Inventors: Liat Mintz, Hanqing Xie, Dvir Dahari, Erez Levanon, Shiri Freilich, Nili Beck, Wei-Yong Zhu, Alon Wasserman, Chen Hermesh, Idit Azar, Jeanne Bernstein
  • Publication number: 20040142325
    Abstract: A method of annotating biomolecular sequences The method comprises (a) computationally clustering the biomolecular sequences according to a progressive homology range, to thereby generate a plurality of clusters each being of a predetermined homology of the homology range; and (b) assigning at least one ontology to each cluster of the plurality of clusters, the at least one ontology being: (i) derived from an annotation preassociated with at least one biomolecular sequence of each cluster; and/or (ii) generated from analysis of the at least onic biomolecular sequence of each cluster thereby annotating biomolecular sequences.
    Type: Application
    Filed: September 13, 2002
    Publication date: July 22, 2004
    Inventors: Liat Mintz, Hanqing Xie, Dvir Dahari, Erez Levanon, Shiri Freilich, Nili Beck, Wei-Yong Zhu, Alon Wasserman, Chen Hermesh, Idit Azar, Jeanne Bernstein
  • Publication number: 20040101876
    Abstract: A method of annotating biomolecular sequences. The method comprises (a) computationally clustering the biomolecular sequences according to a progressive homology range, to thereby generate a plurality of clusters each being of a predetermined homology of the homology range; and (b) assigning at least one ontology to each cluster of the plurality of clusters, the at least one ontology being: (i) derived from an annotation preassociated with at least one biomolecular sequence of each cluster; and/or (ii) generated from analysis of the at least one biomolecular sequence of each cluster thereby annotating biomolecular sequences.
    Type: Application
    Filed: April 30, 2003
    Publication date: May 27, 2004
    Inventors: Liat Mintz, Hanqing Xie, Dvir Dahari, Erez Levanon, Shiri Freilich, Nili Beck, Wei-Yong Zhu, Alon Wasserman, Chen Hermesh, Idit Azar, Jeanne Bernstein, Rotem Sorek